Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Zvi Yammer who wrote (2363)	6/29/1999 6:33:00 PM
From: Walter Morton	Read Replies (1) \| Respond to of 2742

I hope Genome has these kinds of skills: MAST IMMUNOSYSTEMS, INC. Enabling a privately held biotechnology company to attract a higher acquisition price from a minority shareholder. Company: MAST Immunosystems, Inc., a Silicon Valley-based manufacturer of automated in-vitro allergy diagnostic products. Challenge: MAST received an unsolicited offer from an existing 35 percent shareholder to buy the balance of the company's outstanding shares. Management and Directors believed the offering price was too low and sought expert valuation and fairness advice. J&L Strategic Response: We have extensive experience in providing valuations and fairness opinions to small and middle-market companies. We applied expert determination of discounted cash flows, comparable company analysis and an evaluation of market and industry prospects to establish a significantly higher value for the business than previously established. Result: Armed with this information, MAST obtained a final purchase price 60 percent higher than the initial offer. jesuplamont.com